CAMP analyst estimates

CAMP4 Therapeutics (CAMP) analyst ratings, the average price target and its range, and every firm's latest call.

CAMP analyst ratings and price targets

DateFirmCallTarget
Oct 23, 2026Raymond JamesRaymond James Starts CAMP4 Therapeutics Corp (CAMP) at Strong Buy$10.00
Oct 15, 2026NeedhamCamp4 Therapeutics initiated with a Buy at Needham$8.00
Sep 29, 2026Chardan CapitalCamp4 Therapeutics price target lowered to $6 from $6.50 at Chardan$6.00
Aug 14, 2026UBSCamp4 Therapeutics price target raised to $15 from $12 at Piper Sandler$15.00
Jun 10, 2026Chardan CapitalCamp4 Therapeutics initiated with a Buy at Chardan$6.50
Oct 2, 2025Cantor FitzgeraldCamp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald$7.00
Nov 5, 2024Piper SandlerPiper Sandler Starts CAMP4 Therapeutics Corp (CAMP) at Overweight$18.00
Nov 5, 2024Leerink PartnersLeerink Partners Starts CAMP4 Therapeutics Corp (CAMP) at Outperform$17.00
Aug 16, 2022Craig-HallumCraig-Hallum upgrades CalAmp to Buy, raises price target to $10$10.00
Jun 24, 2022Goldman SachsGoldman Sachs cuts CalAmp EBITDA estimates on lower margin forecasts$5.00